Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
Aging research is pivoting from lifespan extension to enhancing healthspan, with innovations like senolytic drugs and digital health tools transforming clinical practices. Recent geroscience advances ...
Recent studies uncover autophagy’s dual role in aging, suggesting early enhancement through lifestyle may delay decline, while late-stage inhibition in senescent cells could reduce inflammation,...
Recent studies on hydra’s negligible senescence overturn traditional aging models, suggesting aging is adaptable and offering clues for anti-aging biotech interventions. New research reveals hyd...
Recent research indicates that nearly half of older adults can defy age-related decline through positive beliefs and structured interventions, enhancing cognitive and physical function. New studies re...
Golden spiny mice exhibit unique immune adaptations that slow aging and enhance regeneration, with recent studies offering hope for human healthspan therapies. Golden spiny mice demonstrate slowed agi...
Recent advancements in cellular reprogramming, including significant funding and clinical trials, are transforming anti-aging science by targeting root causes of age-related diseases. Cellular reprogr...
Recent advances in partial cellular reprogramming using OSKM factors show promise in extending healthspan and treating age-related diseases, with biotech firms accelerating towards human trials. New r...
Recent UK Biobank analysis shows healthy dietary patterns can extend lifespan by 1.5-3.0 years, emphasizing diet as a key modifiable factor for longevity and healthspan extension. New data from UK Bio...
New evidence supports menopausal hormone therapy for reducing mortality and enhancing healthspan, with updated guidelines emphasizing personalized approaches based on recent studies and expert insight...
